Clinical outcomes of temocillin use for invasive Enterobacterales infections: a single-centre retrospective analysis

KL Heard, K Killington, N Mughal… - JAC-Antimicrobial …, 2021 - academic.oup.com
Background With increasing frequency of resistant Gram-negative bacteria, temocillin has
potential utility in reducing carbapenem use. The 2020 EUCAST guideline changes …

[PDF][PDF] Clinical outcomes of temocillin use for invasive Enterobacterales infections: a single-centre retrospective analysis

KL Heard, K Killington, N Mughal… - JAC-Antimicrobial …, 2021 - academic.oup.com
Background With increasing frequency of resistant Gram-negative bacteria, temocillin has
potential utility in reducing carbapenem use. The 2020 EUCAST guideline changes …

Clinical outcomes of temocillin use for invasive Enterobacterales infections: a single-centre retrospective analysis.

KL Heard, K Killington, N Mughal… - Jac-antimicrobial …, 2021 - europepmc.org
Background With increasing frequency of resistant Gram-negative bacteria, temocillin has
potential utility in reducing carbapenem use. The 2020 EUCAST guideline changes …

Clinical outcomes of temocillin use for invasive Enterobacterales infections: a single-centre retrospective analysis

KL Heard, K Killington, N Mughal… - JAC-antimicrobial …, 2021 - pubmed.ncbi.nlm.nih.gov
Background With increasing frequency of resistant Gram-negative bacteria, temocillin has
potential utility in reducing carbapenem use. The 2020 EUCAST guideline changes …

[PDF][PDF] JAC-Antimicrobial Resistance

KL Heard, K Killington, N Mughal, LSP Moore… - scholar.archive.org
Background: With increasing frequency of resistant Gram-negative bacteria, temocillin has
potential utility in reducing carbapenem use. The 2020 EUCAST guideline changes …

[HTML][HTML] Clinical outcomes of temocillin use for invasive Enterobacterales infections: a single-centre retrospective analysis

KL Heard, K Killington, N Mughal… - JAC-Antimicrobial …, 2021 - ncbi.nlm.nih.gov
Background With increasing frequency of resistant Gram-negative bacteria, temocillin has
potential utility in reducing carbapenem use. The 2020 EUCAST guideline changes …

Clinical outcomes of temocillin use for invasive Enterobacterales infections: a single-centre retrospective analysis.

KL Heard, K Killington, N Mughal… - Jac-antimicrobial …, 2021 - europepmc.org
Background With increasing frequency of resistant Gram-negative bacteria, temocillin has
potential utility in reducing carbapenem use. The 2020 EUCAST guideline changes …